TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Number of phage therapy requests
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Awareness of participants regarding PMDD symptoms
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Disability of Arm Hand and Shoulder (DASH)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Retention of CPR training
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effectiveness of CPR training
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Comprehension of CPR training
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Normalization of Hb concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Rate of composite adverse pregnancy outcomes
Endpoint domain: Adverse events/effects
Primary endpoint: Maximum pain during procedures
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Preoperative lactate levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to surgery from admission
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Major Vascular Occlusive events
Endpoint domain: Adverse events/effects
Primary endpoint: Social Networking Addiction Scale (SNAS)
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Secure Flourish Index (SFI)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Fear of Missing Out Scale (FoMOs)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Pubbing Scale (PS)
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Change in Monocyte Platelet Aggregation (MPA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Change in Light Transmission Aggregation (LTA)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Completion of the questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Cardiac manifestation after vaccine injection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: short Crohn's Disease Activity Index (sCDAI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: occlusal stability
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Insulin Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Heart rate variability in time domain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: modified Rankin score
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Acceptability and tolerability
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: BI scale
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: mRS scale
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Number of children selecting the target object
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-Time Curve From Time Zero to the Last Quantifiable Concentration (AUClast) of Sotorasib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Plasma Concentration-Time Curve From Time Zero to Infinity (AUCinf) of Sotorasib
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Case manager satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Case manager productivity
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Case manager note completion time
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Objective response rate of ascites
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time to circulating CAR-T cell loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Duration and severity of hypotension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Mortality among patients administered antivenom
Endpoint domain: Mortality/survival
Primary endpoint: Morbidity among patients administered antivenom
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight change (% kg)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of cut-out
Endpoint domain: Adverse events/effects
Primary endpoint: Hypertensive Phase
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: biochemical/metabolic parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Action picture naming
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of screened eligible patients
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: effectiveness of cognitive behavioral therapy program
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Six Month Progression-Free Survival (PFS6)
Endpoint domain: Mortality/survival
Primary endpoint: Temperature curve (body temperature in °C)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wound infection or pneumonia
Endpoint domain: Adverse events/effects
Primary endpoint: Rate of re-injury
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in number and severity of Post-concussive symptoms (PCSS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Wounds healing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Resolution of pelvi-abdominal infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Misophonia severity
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Blood product utilization
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Alanine transaminase (ALT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of AI model
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Sensitivity of AI model
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of AI model
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in bone metabolic markers β-CTX
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Changes in bone metabolic markers PINP
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Recruitment/consent rate
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Withdrawals
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Selection bias
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in blood flow after smoking
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Oral health-related quality of life of their children
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Sensitivity of Capnography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Specificity of Capnography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall diagnostic performance of Capnography
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Utilization of mental health services
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Effect on anthropometry parameters
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Effect on depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Effect on quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Perceived Autonomy Support
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of Participants Achieving Responder Status for Evaluating Investigator's (EI) live assessment of Mid Face Volume Deficit Scale (MFVDS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Assisting Hand Assessment (AHA) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Prematurity
Endpoint domain: Mortality/survival
Primary endpoint: Neonatal Mortality rate
Endpoint domain: Mortality/survival
Primary endpoint: Change from Baseline of Appendicular skeletal muscle mass index at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Change from Baseline of grip strength at 12 weeks
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Ability to Detect Minor Blood Loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Ability to Detect Saline Reinfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: GADA levels in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in Moral Injury and Distress Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Moral Injury Outcomes Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Expressions of Moral Injury Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in Religious and Spiritual Struggles Scale
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Retention and turnover
Endpoint domain: Life impact
Endpoint subdomain: Employment circumstances
Primary endpoint: Number of participants with severe, life-threatening or fatal adverse events
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants who die in the hospital
Endpoint domain: Mortality/survival
Primary endpoint: Patient Controlled Analgesia morphine consumption
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: obstetric quality of recovery score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Capillary blood glucose levels in newborns
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Completion of ≥6 Pulmonary Rehabilitation sessions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in annualized growth velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from baseline in age-sex standardized height standard deviation score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total Number of Eligible Adults Enrolled in the Study
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Percentage of Intervention Sessions Attended
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Change in gait kinematics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in gait kinetics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in gait metabolics
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in white matter integrity (fractional anisotropy)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of participants who don't relapse (cocaine-negative urine drug screens)
Endpoint domain: Adverse events/effects
Primary endpoint: Change in back-related disability
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Percentage of participants with RSV-associated MALRI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Percentage of participants with fever
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants with anaphylaxis/hypersensitivity AE of special interest (AESI)
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of participants with rash AESI
Endpoint domain: Adverse events/effects
Primary endpoint: Clinical characteristics of patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biological characteristics of patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Spine posture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient comprehension
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of inconclusive biopsies
Endpoint domain: Adverse events/effects
Primary endpoint: Retention and completeness of patient-reported outcome measures
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from baseline in CLDEQ-8 total score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Safety of TIL
Endpoint domain: Adverse events/effects
Primary endpoint: Safety of Cryoneurolysis compared to Radiofrequency Ablation
Endpoint domain: Adverse events/effects
Primary endpoint: Union of tibial fracture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: proportion of patients who develop contact dermatitis
Endpoint domain: Adverse events/effects
Primary endpoint: Postoperative blood transfusion
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Changes in safety laboratory parameters from baseline by the FDA toxicity grading scale
Endpoint domain: Adverse events/effects
Primary endpoint: Change in plasma EPA and DHA content
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in oral feed intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in intravenous infusion intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Glygocalyx integrity - perfused boundary region
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the number of migraine days in a month
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average reduction of POSAS scar severity measure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Complications related to TEE use
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of oropharyngeal swabs positive for GAS each month
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Prevalence of normal skin swabs positive for GAS each month
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Incidence of GAS-positive oropharyngeal swabs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Incidence of GAS-positive normal skin swabs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Change in GAS-positive swabs per month
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Plasma Area Under the Curve (AUC(0 to 72hr)) for Linagliptin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peak Plasma Concentration (Cmax) of Linagliptin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biological (epigenetic) age
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Automated computer detection of spasms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achievement of Complete Disease Remission
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: partial pressure of oxygen (PaO2)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Incidence of solicited local reactogenicity signs and symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of solicited systemic reactogenicity signs and symptoms
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of unsolicited adverse events in study participants
Endpoint domain: Adverse events/effects
Primary endpoint: Occurrence of adverse events of special interest (AESI), including potentially immune mediated disorders (pIMD)
Endpoint domain: Adverse events/effects
Primary endpoint: Rearrests
Endpoint domain: Adverse events/effects
Primary endpoint: Convictions
Endpoint domain: Adverse events/effects
Primary endpoint: Reincarcerations
Endpoint domain: Adverse events/effects
Primary endpoint: Noticing and recall of added-sugar nutrient label
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Recognition of label
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Proportion of immune cells in BAL fluid
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Detection of SARS-CoV-2 positive and negative strand RNA
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: changes in Korean modified Barthel Index (K-MBI)
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Fugl-Meyer Assessment for Upper Extremity (FMA-UE) scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Parkinson's disease quality of life-39 scores
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Modified Schober Index
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Bath AS Metrology Index (BASMI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Tandem stance test
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Falls Efficacy Scale-International
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Serum lactate peak (Lmax) during Cardiopulmonary by-pass
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Percentage of patients receiving at least one dose of personalized neoantigen vaccine
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Changes in immediate verbal attention
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes in processing speed
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: Changes in verbal memory
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cognitive functioning
Primary endpoint: cutaneous microvascular function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: peripheral sensorial neurological function
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Incidence and Characteristics of Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Change in quantity of leg cramps
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Functional Dyspepsia Symptom Severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Body Fat Content Analysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Frequency of AEs, SAEs, lab abnormalities, AESIs
Endpoint domain: Adverse events/effects
Primary endpoint: skin prick tests as biomarkers of preschool wheeze
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: eosinophil count as a biomarker of preschool wheeze
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: blood neutrophil phenotype as a biomarker of airway infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: blood neutrophil chemotaxis as a biomarker of wheezing phenotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: oropharyngeal swab and induced sputum PCR as a biomarker of airway infection
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Changes in optic nerve sheath diameter (ONSD)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Mean absolute change in lumbar spine (L1-L4) Z-score in adolescents
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mean percentage change in lumbar spine (L1-L4) BMD in adults
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Biomechanical properties of plantar fascia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Viscoelastic properties of plantar fascia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Achenbach System for Empirically Assessment (ASEBA)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Stirling Children's Wellbeing Scale (SCWBS)
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Child Well-Being Level (CWBL)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of correct answers to the recall-assessing items
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning